Related Experiment Video
Updated: May 26, 2026

Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder
Published on: March 8, 2018
Use of Lorazepam in drug-assisted interviews: two cases of dissociative amnesia
Sang-Shin Lee1, Sinhyung Park, Si-Sung Park
1Department of Neuropsychiatry, Kosin University Gospel Hospital, Busan, Korea.
Abstract:
Drug-assisted interviews are useful for psychiatric diagnosis and treatment. However, amobarbital, a typical medication used for this purpose, is associated with elevated risk of respiratory depression. Benzodiazepines are good substitutes for amobarbital, with similar therapeutic effects and fewer complications. Although drug-assisted interviews are not widely used, they may be beneficial for selected patients who do not respond to conventional treatments such as supportive psychotherapy or psychopharmacotherapy. We report two cases of dissociative amnesia that were treated using lorazepam-assisted interviews. The use of lorazepam in drug-assisted interviews is effective and safe for resolving dissociative amnesia.
Insights
Lorazepam-assisted interviews offer a safe and effective alternative for treating dissociative amnesia. This method provides therapeutic benefits similar to traditional amobarbital interviews but with reduced respiratory risks.
Area of Science:
- Psychiatry
- Pharmacology
- Neurology
Background:
- Drug-assisted interviews aid psychiatric diagnosis and treatment.
- Amobarbital, a common agent, carries risks like respiratory depression.
- Benzodiazepines present a safer alternative with comparable efficacy.
Purpose of the Study:
- To evaluate the efficacy and safety of lorazepam-assisted interviews for dissociative amnesia.
- To explore alternatives to amobarbital for drug-assisted interviews.
Main Methods:
- Case study of two patients with dissociative amnesia.
- Utilized lorazepam-assisted interviews for treatment.
- Assessed treatment outcomes and safety profile.
Main Results:
- Lorazepam-assisted interviews were effective in resolving dissociative amnesia in both cases.
- The treatment demonstrated a favorable safety profile with no reported complications.
- This method proved beneficial for patients unresponsive to conventional therapies.
Conclusions:
- Lorazepam-assisted interviews are a safe and effective therapeutic option for dissociative amnesia.
- Benzodiazepines like lorazepam are viable substitutes for amobarbital in drug-assisted interviews.
- This approach may benefit selected patients with treatment-resistant dissociative amnesia.
Related Concept Videos
Dissociative Amnesia
CNS Depressants: Barbiturates and Benzodiazepines
Dissociative Disorders
Dissociative Fugue
A hallmark feature of dissociative disorders is the dissociative fugue...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
